These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24408112)

  • 1. CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2013 Nov; 19(1):357-64. PubMed ID: 24408112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.
    Koppel J; Vingtdeux V; Marambaud P; d'Abramo C; Jimenez H; Stauber M; Friedman R; Davies P
    Mol Med; 2014 Mar; 20(1):29-36. PubMed ID: 24722782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
    Schmöle AC; Lundt R; Toporowski G; Hansen JN; Beins E; Halle A; Zimmer A
    J Alzheimers Dis; 2018; 64(2):379-392. PubMed ID: 29865078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid CB
    López A; Aparicio N; Pazos MR; Grande MT; Barreda-Manso MA; Benito-Cuesta I; Vázquez C; Amores M; Ruiz-Pérez G; García-García E; Beatka M; Tolón RM; Dittel BN; Hillard CJ; Romero J
    J Neuroinflammation; 2018 May; 15(1):158. PubMed ID: 29793509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.
    Kim WS; Li H; Ruberu K; Chan S; Elliott DA; Low JK; Cheng D; Karl T; Garner B
    J Neurosci; 2013 Mar; 33(10):4387-94. PubMed ID: 23467355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body vibration ameliorates glial pathological changes in the hippocampus of hAPP transgenic mice, but does not affect plaque load.
    Oroszi T; Geerts E; Rajadhyaksha R; Nyakas C; van Heuvelen MJG; van der Zee EA
    Behav Brain Funct; 2023 Mar; 19(1):5. PubMed ID: 36941713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network.
    Takahashi H; Klein ZA; Bhagat SM; Kaufman AC; Kostylev MA; Ikezu T; Strittmatter SM;
    Acta Neuropathol; 2017 May; 133(5):785-807. PubMed ID: 28070672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease.
    Wright AL; Zinn R; Hohensinn B; Konen LM; Beynon SB; Tan RP; Clark IA; Abdipranoto A; Vissel B
    PLoS One; 2013; 8(4):e59586. PubMed ID: 23560052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.
    Aso E; Andrés-Benito P; Carmona M; Maldonado R; Ferrer I
    J Alzheimers Dis; 2016; 51(2):489-500. PubMed ID: 26890764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model.
    Thanopoulou K; Fragkouli A; Stylianopoulou F; Georgopoulos S
    Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20816-21. PubMed ID: 21076037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
    Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
    J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
    [No Abstract]   [Full Text] [Related]  

  • 16. Sphingosine Kinase 2 Potentiates Amyloid Deposition but Protects against Hippocampal Volume Loss and Demyelination in a Mouse Model of Alzheimer's Disease.
    Lei M; Teo JD; Song H; McEwen HP; Yup Lee J; Couttas TA; Duncan T; Chesworth R; Bertz J; Przybyla M; Van Eersel J; Heng B; Guillemin GJ; Ittner LM; Fath T; Garner B; Ittner A; Karl T; Don AS
    J Neurosci; 2019 Nov; 39(48):9645-9659. PubMed ID: 31641049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C; Inestrosa NC
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
    Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
    J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.
    Clayton K; Delpech JC; Herron S; Iwahara N; Ericsson M; Saito T; Saido TC; Ikezu S; Ikezu T
    Mol Neurodegener; 2021 Mar; 16(1):18. PubMed ID: 33752701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
    Ochiai T; Sano T; Nagayama T; Kubota N; Kadowaki T; Wakabayashi T; Iwatsubo T
    Neurobiol Dis; 2021 Nov; 159():105510. PubMed ID: 34537327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.